» Articles » PMID: 17173715

Modifiable Risk Factors for Developing Diabetes Among Women with Previous Gestational Diabetes

Overview
Specialty Public Health
Date 2006 Dec 19
PMID 17173715
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Gestational diabetes mellitus (GDM) affects approximately 2% to 4% of all pregnant women in the United States each year. Women who have had GDM are at high risk for developing nongestational diabetes. The objective of this study was to assess the prevalence of modifiable risk factors for developing diabetes among women with previous GDM only.

Methods: Cross-sectional data for nonpregnant women from the 2003 Behavioral Risk Factor Surveillance System were used to estimate and compare the prevalence of modifiable risk factors among three groups: nonpregnant women with previous GDM only, nonpregnant women with current diabetes, and nonpregnant women without diabetes.

Results: In 2003, 7.6% of nonpregnant women aged 18 years and older in the United States had current self-reported physician-diagnosed diabetes, and 1.5% had previous GDM only. Compared with women without diabetes, women with previous GDM only had higher prevalence of no leisure-time physical activity (32.0% vs 25.7%), overweight (62.2% vs 49.0%), and obesity (29.4% vs 20.0%). After adjusting for sociodemographic variables, women with previous GDM only were more likely to have no leisure-time physical activity (prevalence odds ratio [POR], 1.4; 95% confidence interval [CI], 1.2-1.7) and more likely to be overweight (POR, 1.8; 95% CI, 1.6-2.2) or obese (POR, 1.7; 95% CI, 1.4-2.1), compared with women with no diabetes.

Conclusion: Women with previous GDM are more likely to have modifiable risk factors for developing diabetes than women without diabetes. More attention to this issue is needed from health care providers and public health officials to encourage the promotion of healthy lifestyles during and after pregnancy.

Citing Articles

Modifiable Risk Factors and Trends in Changes in Glucose Regulation during the First Three Years Postdelivery: The St Carlos Gestational Diabetes Mellitus Prevention Cohort.

Arnoriaga-Rodriguez M, Melero V, Barabash A, Valerio J, Valle L, OConnor R Nutrients. 2023; 15(23).

PMID: 38068853 PMC: 10707889. DOI: 10.3390/nu15234995.


Impact of Obesity and Hyperglycemia on Pregnancy-specific Urinary Incontinence.

Vesentini G, Piculo F, Marini G, Barbosa A, Corrente J, Rudge M Rev Bras Ginecol Obstet. 2023; 45(6):303-311.

PMID: 37494572 PMC: 10411106. DOI: 10.1055/s-0043-1770087.


A pragmatic lifestyle intervention for overweight and obese women with gestational diabetes mellitus (PAIGE2): A parallel arm, multicenter randomized controlled trial study protocol.

McAuley E, Fleck O, Cassidy L, Kemp B, Cupples G, Kelly B Front Clin Diabetes Healthc. 2023; 4:1118509.

PMID: 37034478 PMC: 10080069. DOI: 10.3389/fcdhc.2023.1118509.


Gestational diabetes mellitus: The prevalence, associated factors and foeto-maternal outcome of women attending antenatal care.

Logakodie S, Azahadi O, Fuziah P, Norizzati B, Tan S, Zienna Z Malays Fam Physician. 2018; 12(2):9-17.

PMID: 29423124 PMC: 5802775.


Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus.

Li Y, Xiao R, Li C, Huangfu J, Mao J Med Sci Monit. 2015; 21:426-31.

PMID: 25659997 PMC: 4329941. DOI: 10.12659/MSM.892431.


References
1.
Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18):1343-50. DOI: 10.1056/NEJM200105033441801. View

2.
Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

3.
Cheung N, Byth K . Population health significance of gestational diabetes. Diabetes Care. 2003; 26(7):2005-9. DOI: 10.2337/diacare.26.7.2005. View

4.
Davies G, Wolfe L, Mottola M, MacKinnon C . Joint SOGC/CSEP clinical practice guideline: exercise in pregnancy and the postpartum period. Can J Appl Physiol. 2003; 28(3):330-41. View

5.
Persson B, Hanson U, Hartling S, Binder C . Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes. 1991; 40 Suppl 2:136-41. DOI: 10.2337/diab.40.2.s136. View